May 20, 2011

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

May 19, 2011

Specialty pharmacy provider Assured Pharmacy said first-quarter net sales jumped to $4.4 million for the period ended March 31, an increase of 22.4% from the year-ago quarter.

May 19, 2011

Despite the promise of oral drugs for treating cancer, high costs and the burden of taking multiple medications drive 10% of patients prescribed the drugs not to fill their initial prescriptions, according to a new study published in the Journal of Oncology Practice and the American Journal of Managed Care.

May 18, 2011

Global spending on medicines will reach nearly $1.1 trillion by 2015, according to a new study by market research firm IMS Health.

May 18, 2011

Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

May 18, 2011

A branded drug made by Watson Pharmaceuticals reduced symptoms in men with prostate disease, according to results of a mid-stage clinical trial.

May 18, 2011

A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.

May 17, 2011

An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

May 16, 2011

Drug maker Eli Lilly will present data from more than 30 studies at the American Society of Clinical Oncology’s annual meeting in Chicago next month, the company said Monday.

May 16, 2011

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 12, 2011

A subsidiary of Johnson & Johnson is recalling several batches of an HIV drug after reports of a strange odor that may have come from the shipping pallets.

May 11, 2011

Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.

May 11, 2011

The seventh annual Armada Specialty Pharmacy Summit, convened at The Wynn resort and casino this week, attracted nearly 1,500 attendees — a rise of almost 50% over 2010 — and about 80 exhibiting companies.

May 11, 2011

Patients with moderate to severe rheumatoid arthritis who respond to 12 weeks of treatment with a drug made by UCB are more likely to show improvement in their condition in the long run, according to results of a study published in the Journal of Rheumatology.

May 10, 2011

The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.

May 9, 2011

The Food and Drug Administration has granted orphan drug designation to a treatment made by Mithridion for a rare neurological disorder, Mithridion said Monday.

May 9, 2011

French drug maker Sanofi-Aventis has shortened its name to Sanofi, the company said.

May 6, 2011

The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

May 3, 2011

First quarter 2011 sales at specialty pharmacy provider BioScrip increased by 31.1% over first quarter 2010.

May 2, 2011

Armada Health Care has launched a new Web-based specialty pharmacy therapy management system designed to allow pharmacies to optimize drug utilization and clinical outcomes while providing enhanced patient care, Armada said Monday.

May 2, 2011

Cephalon has another suitor in the form of the world’s largest generic drug company.

April 29, 2011

Diplomat Specialty Pharmacy president and CEO Phil Hagerman has been named the Grant Thornton Leader & Innovator of the Year, Diplomat said Friday.

April 29, 2011

The Food and Drug Administration has approved a new treatment for prostate cancer made by Johnson & Johnson.